- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02884232
Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort (CERBois)
August 25, 2016 updated by: Central Hospital, Nancy, France
Application of Guidelines for Medico-professional Supervision of Workers Exposed to Carcinogenic Action of Wood Dust: CERBois Cohort. Feasibility Evaluation
The purpose is to evaluate feasibility of medical supervision of professionally active asymptomatic wood workers with questionnaires and nasofibroscopy.
Secondary purposes are:
- Feasibility evaluation of identification of former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics in case of co-expositions (formaldehyde, chrome, nickel, leather)
- Description of abnormal symptoms identified by occupational doctor and needing an otorhinolaryngology test
- Description of results and examinations induced by nasofibroscopy in symptomatic or asymptomatic individuals: counting of naso-sinusal adenocarcinoma cases
- Evaluation of participation of workers retiring in 2 years after inclusion to medical supervision program
- Evaluation of information flow among different players
- Assessment of costs induced by this targeted screening: direct medical costs (screened pathologies, induced additional examinations…) and indirect costs for company (duration of worker absence for transfer, medical and additional examinations).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
800
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Bordeaux, France
- AHI 33
-
Lille, France
- Pôle Santé Travail
-
Paris, France
- Gnmst-Btp
-
Paris, France
- Ville de Paris
-
Suresnes, France
- ACMS
-
Vandoeuvre Les Nancy, France
- Centres de Consultations de Pathologies Professionnelles
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
44 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Population under analysis consists of all workers seen in occupational health consultation and exposed to wood dust at least for cumulated 12 months and with first exposition back to more than 30 years
Description
Inclusion Criteria:
- Employee or craftsman
- Actual or former professional exposition to wood dust
- Onset of exposition to wood dust back to more than 30 years (latency >30 years)
- Cumulated exposition to wood dust longer than 12 months
- Exposition to wood dust during machining tasks (sawing, milling, planing, drilling, bridging) or all documented activities exposing to wood dust concentration > 1 mg/m3 for 8 hours
- Worker followed by occupational doctor of participant occupational health departments
- Worker accepting medico-professional supervision recommended by guidelines
- Affiliation to social security
Exclusion Criteria:
- Difficulty with comprehension of wood auto-questionnaire
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Workers exposed to wood dust
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: Day 0
|
Day 0
|
|
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: 3 months
|
3 months
|
|
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: 24 months
|
24 months
|
|
Participation to medical supervision program of professionally active asymptomatic workers
Time Frame: 27 months
|
27 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Former and actual professional expositions to wood dust and to various naso-sinusal carcinogenics
Time Frame: Day 0
|
Day 0
|
|
Presence of abnormal symptoms assessed by doctor, needing an otorhinolaryngology test
Time Frame: Day 0
|
Day 0
|
|
Presence of abnormal symptoms assessed by doctor, needing an otorhinolaryngology test
Time Frame: 24 months
|
24 months
|
|
Counting of diagnoses of naso-sinusal adenocarcinoma in symptomatic and asymptomatic workers after nasofibroscopy
Time Frame: 3 months
|
3 months
|
|
Counting of diagnoses of naso-sinusal adenocarcinoma in symptomatic and asymptomatic workers after nasofibroscopy
Time Frame: 27 months
|
27 months
|
|
Participation to medical supervision program of workers retiring in 2 years after inclusion
Time Frame: Day 0
|
Day 0
|
|
Evaluation of information flow among different players
Time Frame: 3 months
|
3 months
|
|
Evaluation of information flow among different players
Time Frame: 27 months
|
27 months
|
|
Medical costs Induced by screening
Time Frame: 3 months
|
3 months
|
|
Medical costs Induced by screening
Time Frame: 27 months
|
27 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Christophe PARIS, Pr, Centre de Consultations de Pathologies Professionnelles - Hôpitaux de Brabois - CHU de Nancy - France
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
June 1, 2016
Study Completion (Actual)
June 1, 2016
Study Registration Dates
First Submitted
August 23, 2016
First Submitted That Met QC Criteria
August 25, 2016
First Posted (Estimate)
August 30, 2016
Study Record Updates
Last Update Posted (Estimate)
August 30, 2016
Last Update Submitted That Met QC Criteria
August 25, 2016
Last Verified
August 1, 2016
More Information
Terms related to this study
Other Study ID Numbers
- 2011/INCA/CERBOIS/PARIS-HERIN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Exposition to Wood Dust
-
Astellas Pharma Global Development, Inc.Active, not recruitingAllergic to House Dust MitesGermany
-
Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd.Not yet recruitingAllergic Rhinitis Due to Dust MiteChina
-
Michigan State UniversityRecruitingElevated Blood Lead Levels | Exposure to Toxic DustUnited States
-
NYU Langone HealthNational Institute for Occupational Safety and Health (NIOSH/CDC)Recruiting
-
Hospices Civils de LyonCompletedNeurological Development After Exposition to an Antenatal Nuchal Translucency
-
University Hospital, MontpellierAstraZeneca; ALK-Abelló A/S; ThermoFisher Scientific Brahms Biomarkers France; University...Not yet recruitingSevere Asthma | Allergy to House Dust Mites
-
Abionic SAJohns Hopkins University; NAMSAWithdrawnAllergy | Allergic Asthma | Allergy to Cats | Allergy to House Dust | Allergy to Dog Dander | Allergy CockroachUnited States
-
Abionic SAJohns Hopkins University; NAMSAWithdrawnAllergy | Allergic Asthma | Allergy to Cats | Allergy to House Dust | Allergy Cockroach | Allergy to Dog Dander (Finding) | Allergy MoldUnited States
-
T-Balance Therapeutics GmbHCompletedAllergic Asthma | Allergy to House Dust MiteGermany
-
Cytos Biotechnology AGCompletedPerennial Allergy to House Dust Mite and/or CatEstonia, Latvia, Lithuania
Clinical Trials on Nasofibroscopy
-
Assiut UniversityUnknown
-
University Hospital, RouenRecruitingAdults Patients Undergoing Major Lung Resection in the Context of Lung CancerFrance
-
Hopital FochCompleted
-
University Hospital, LilleTerminatedScleroderma | Olfactory DisordersFrance
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, FranceActive, not recruitingHead and Neck Squamous Cell CarcinomaFrance